NIH-funded research R01 grant

Understanding how inherited prion diseases affect the brain

Official title: Mechanisms of Neurodegeneration in Hereditary Prion Diseases

Funded at Boston University Medical Campus · NIH-11168162 · Data updated 2026-11-12

This study is looking at how certain gene changes related to hereditary prion diseases affect brain cells, using special lab-grown cells to better understand how these changes might lead to problems like Alzheimer's disease.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBoston University Medical Campus
NIH-funded
Lab location1 site (Boston, United States)
Project startJune 1, 2025
Project endMay 31, 2030
Funding year2025
Award (this year)$869,478
NIH project number1R01NS143202-01
Project IDNIH-11168162 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals with a family history of hereditary prion diseases or specific mutations in the PRNP gene.

Less likely to help

Patients with sporadic forms of prion diseases or those without genetic mutations related to prion disorders may not benefit from this research.

What this research studies

This research investigates the cellular and molecular mechanisms behind hereditary prion diseases, particularly focusing on how mutations in the PRNP gene lead to neurodegeneration. By utilizing innovative induced pluripotent stem cell (iPSC) technology, the study aims to analyze the effects of mutant prion proteins on human neurons and glial cells. The goal is to uncover the toxic properties of these proteins and their interactions within the brain, which could provide insights into the progression of related conditions like Alzheimer's disease.

Why it matters

Potential benefit: If successful, this research could lead to new therapeutic strategies for treating neurodegenerative diseases linked to prion mutations.

How similar studies have gone: Previous research has shown promise in understanding prion diseases through animal models, but this approach using human-derived cells is relatively novel.

Where this research is happening

  • Boston University Medical Campus
    Boston, United States
    Active

Researchers

  • Principal investigator: Harris, David a — Boston University Medical Campus
  • Study coordinator: Harris, David a

Related research

Other NIH-funded projects on the same topics.

  • Creating a detailed map of early lung cancer changes

    This study is looking at early changes in lung tissue that can lead to cancer, specifically focusing on common types of lung cancer, and it's for patients who want to help researchers understand these changes better so they can improve early detection and treatment.

    NIH research Boston University Medical Campus · Boston, United States · NIH-9627274

  • Telomere trouble in ALT cancers: what causes damage and how it happens

    Researchers are studying why some cancer cells use ALT to lengthen telomeres and how replication stress damages telomeres, aiming to uncover key processes that could be targeted in patients.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11630744

  • IL-6 signaling, lung injury, and post-TB lung disease in TB/HIV

    This grant tests how a specific immune signal (IL-6) relates to lung damage after tuberculosis in people with and without HIV, aiming to understand who is at risk for lasting lung problems.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11604270

  • IL-6 signaling and lung injury after TB and HIV co-infection

    This project looks at how a common immune signal called IL-6 relates to lung injury after TB treatment, especially in people who also have HIV.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11604269

  • LEAD Africa: advancing Alzheimer’s research across Africa

    A new project aims to build Alzheimer’s disease research capabilities in Africa to improve understanding and care for people with dementia.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11599552

  • Leading AD and related dementias research in Africa

    A multi-country effort aims to build Africa’s capacity to study Alzheimer’s disease and related dementias using scalable, low-cost methods.

    NIH research Boston University Medical Campus · Boston, United States · NIH-11599551

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.